Cargando…

Long Non-Coding RNA in Drug Resistance of Non-Small Cell Lung Cancer: A Mini Review

Lung cancer is one of main causes of cancer mortality and 83% of lung cancer cases are classified as non-small cell lung cancer (NSCLC). Patients with NSCLC usually have a poor prognosis and one of the leading causes is drug resistance. With the progress of drug therapy, the emergence and developmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Ruizheng, Wang, Ranran, Chang, Siyuan, Li, Kexin, Sun, Rongsi, Wang, Mengnan, Li, Zheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930187/ https://www.ncbi.nlm.nih.gov/pubmed/31920650 http://dx.doi.org/10.3389/fphar.2019.01457

Ejemplares similares

Anoikis-related long non-coding RNA signatures to predict prognosis and small molecular drug response in cervical cancer
por: Liang, Hao, et al.
Publicado: (2023)

Genetic Association of Drug Response to Erlotinib in Chinese Advanced Non-small Cell Lung Cancer Patients
por: Wang, Cong, et al.
Publicado: (2018)

Guaiazulene Triggers ROS-Induced Apoptosis and Protective Autophagy in Non-small Cell Lung Cancer
por: Ye, Qin, et al.
Publicado: (2021)

MGA Mutation as a Novel Biomarker for Immune Checkpoint Therapies in Non-Squamous Non-Small Cell Lung Cancer
por: Sun, Lei, et al.
Publicado: (2021)

Long non-coding RNAs in lung cancer: Regulation patterns, biologic function and diagnosis implications (Review)
por: Jiang, Lin, et al.
Publicado: (2019)

The anti-diabetic effects of metformin are mediated by regulating long non-coding RNA
por: Chang, Wenguang, et al.
Publicado: (2023)

Insights into the involvement of long non-coding RNAs in doxorubicin resistance of cancer
por: Zhang, Hai-Bo, et al.
Publicado: (2023)

Long Non-Coding RNA-Mediated Competing Endogenous RNA Networks in Ischemic Stroke: Molecular Mechanisms, Therapeutic Implications, and Challenges
por: Zhang, Shuxia, et al.
Publicado: (2021)

Current status of immunotherapy for non-small cell lung cancer
por: Yang, Tao, et al.
Publicado: (2022)

Role of long non‐coding RNA in drug resistance in non‐small cell lung cancer
por: Wang, Leirong, et al.
Publicado: (2018)

In vitro Non-Small Cell Lung Cancer Inhibitory Effect by New Diphenylethane Isolated From Stems and Leaves of Dioscorea oppositifolia L. via ERβ-STAT3 Pathway
por: Zeng, Mengnan, et al.
Publicado: (2021)

METTL7B Is Required for Cancer Cell Proliferation and Tumorigenesis in Non-Small Cell Lung Cancer
por: Liu, Dongcheng, et al.
Publicado: (2020)

Silencing of Long Non-coding RNA MIAT Sensitizes Lung Cancer Cells to Gefitinib by Epigenetically Regulating miR-34a
por: Fu, Yunfeng, et al.
Publicado: (2018)

A Prognostic Model Based on Immune-Related Long Non-Coding RNAs for Patients With Cervical Cancer
por: Chen, Peijie, et al.
Publicado: (2020)

Co-Expression Networks Unveiled Long Non-Coding RNAs as Molecular Targets of Drugs Used to Treat Bipolar Disorder
por: Truong, Trang TT., et al.
Publicado: (2022)

Addition of metformin for non-small cell lung cancer patients receiving antineoplastic agents
por: Wang, Yan, et al.
Publicado: (2023)

Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab
por: Jiang, Fenge, et al.
Publicado: (2022)

The Role of Exosomal Non-Coding RNAs in Coronary Artery Disease
por: Liu, Jia, et al.
Publicado: (2020)

Corrigendum: A Prognostic Model Based on Immune-Related Long Non-Coding RNAs for Patients With Cervical Cancer
por: Chen, Peijie, et al.
Publicado: (2021)

The emerging role of long non-coding RNAs in renal cell carcinoma progression and clinical therapy via targeting metabolic regulation
por: Gao, Xingyu, et al.
Publicado: (2023)

Long non-coding RNAs as potential therapeutic targets in non-small cell lung cancer (Review)
por: Tang, Peiyu, et al.
Publicado: (2023)

The Landscape of Exosome-Derived Non-Coding RNA in Leukemia
por: Tang, Bing-Jie, et al.
Publicado: (2022)

Analysis of the long non-coding RNA LINC01614 in non-small cell lung cancer
por: Sun, Yan, et al.
Publicado: (2019)

Discovery of Small Molecule NSC290956 as a Therapeutic Agent for KRas Mutant Non-Small-Cell Lung Cancer
por: Zhang, Jiaxin, et al.
Publicado: (2022)

Immunotherapy for a POLE Mutation Advanced Non-Small-Cell Lung Cancer Patient
por: Fu, Yang, et al.
Publicado: (2022)

Extracellular Vesicles as Carriers of Non-coding RNAs in Liver Diseases
por: Yang, Junfa, et al.
Publicado: (2018)

The Emerging Role of Long Non-Coding RNAs in Esophageal Cancer: Functions in Tumorigenesis and Clinical Implications
por: Han, Yali, et al.
Publicado: (2022)

Long non-coding RNAs in non-small cell lung cancer: functions and distinctions from other malignancies
por: Wang, Maolong, et al.
Publicado: (2019)

A novel defined risk signature of cuproptosis-related long non-coding RNA for predicting prognosis, immune infiltration, and immunotherapy response in lung adenocarcinoma
por: Ma, Chao, et al.
Publicado: (2023)

Screening and Verification of Differentially Expressed Long Non-coding RNAs in the Peripheral Blood of Patients With asthma
por: Ma, Cheng, et al.
Publicado: (2022)

miRNAs in anti-cancer drug resistance of non-small cell lung cancer: Recent advances and future potential
por: Yan, Hang, et al.
Publicado: (2022)

Osimertinib as Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: A Case Series
por: Hu, Yan, et al.
Publicado: (2022)

Peptides/Proteins Encoded by Non-coding RNA: A Novel Resource Bank for Drug Targets and Biomarkers
por: Zhu, Song, et al.
Publicado: (2018)

Non-coding RNA-related antitumor mechanisms of marine-derived agents
por: Zhou, Zhixia, et al.
Publicado: (2022)

The Role of Prostaglandin-Endoperoxide Synthase-2 in Chemoresistance of Non-Small Cell Lung Cancer
por: Lin, Xiao-mian, et al.
Publicado: (2019)

USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway
por: Xue, Sudong, et al.
Publicado: (2020)

Long non-coding RNAs in intracerebral hemorrhage
por: Zhang, Chenyu, et al.
Publicado: (2023)

Quantitative comparison of the efficacies and safety profiles of three first-line non-platinum chemotherapy regimens for advanced non-small cell lung cancer
por: Yang, Qian-Yu, et al.
Publicado: (2022)

The Relationship Between Short-Term Surrogate Endpoint Indicators and mPFS and mOS in Clinical Trials of Malignant Tumors: A Case Study of Approved Molecular Targeted Drugs for Non-Small-Cell Lung Cancer in China
por: Rui, Mingjun, et al.
Publicado: (2022)

Targeting glycolysis in non-small cell lung cancer: Promises and challenges
por: Xu, Jia-Qi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cfqe3fn15u8odjviraa185qcce